TEAS Plus New Application

CONVERSALL, ELLIPSIS

Vivera Pharmaceuticals Inc.

Trademark/Service Mark Application, Principal Register

PTO- 1478
Approved for use through 08/31/2021. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number

Trademark/Service Mark Application, Principal Register

TEAS Plus Application

Serial Number: 90904032
Filing Date: 08/26/2021

NOTE: Data fields with the * are mandatory under TEAS Plus. The wording "(if applicable)" appears where the field is only mandatory under the facts of the particular application.


The table below presents the data as entered.

Input Field
Entered
TEAS Plus YES
MARK INFORMATION
*MARK \\TICRS\EXPORT18\IMAGEOUT 18\909\040\90904032\xml1 \ FTK0002.JPG
*SPECIAL FORM YES
USPTO-GENERATED IMAGE NO
LITERAL ELEMENT Conversall, ellipsis
*COLOR MARK YES
*DESCRIPTION OF THE MARK
(and Color Location, if applicable)
The mark consists of The wording Conversall in blue, with an ellipsis in blue, a stylized word balloon in light blue and red, and a stylized brain icon in blue.
*COLOR(S) CLAIMED
(If applicable)
The color(s) light blue, blue, red is/are claimed as a feature of the mark.
PIXEL COUNT ACCEPTABLE YES
PIXEL COUNT 944 x 605
REGISTER Principal
APPLICANT INFORMATION
*OWNER OF MARK Vivera Pharmaceuticals Inc.
*MAILING ADDRESS 4533 Macarthur Blvd, #5049
*CITY Newport Beach
*STATE
(Required for U.S. applicants)
California
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
92660
PHONE 949-234-6161
*EMAIL ADDRESS XXXX
LEGAL ENTITY INFORMATION
*TYPE CORPORATION
* STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY OF INCORPORATION Delaware
GOODS AND/OR SERVICES AND BASIS INFORMATION
*INTERNATIONAL CLASS 005 
*IDENTIFICATION Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Gelatin capsules sold empty for pharmaceuticals; Medicinal preparations for mental health disorders; Medicinal preparations for stuttering; Medicinal preparations for diabetes; Dietary supplements; Drug delivery agents in the form of sublingual tablets that facilitate the delivery of pharmaceutical preparations; Drug delivery agents in the form of sublingual capsules that facilitate the delivery of pharmaceutical preparations; Drug delivery agents in the form of sublingual gel strips that facilitate the delivery of pharmaceutical preparations; Medical preparations for the treatment of mental health disorders; Medical preparations for the treatment of stuttering; Medical preparations for the treatment of diabetes; Nutritional supplements; Pharmaceutical preparations for mental health disorders; Pharmaceutical preparations for stuttering; Pharmaceutical preparations for diabetes; Prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets and pharmaceutical preparations for the treatment of cardiovascular disorders; Sexual stimulant preparations in the form of sublingual tablets containing sildenafil citrate; Sexual stimulant preparations in the form of sublingual capsules containing sildenafil citrate; Sexual stimulant preparations in the form of sublingual gel strips containing sildenafil citrate
*FILING BASIS SECTION 1(b)
ADDITIONAL STATEMENTS SECTION
*TRANSLATION
(if applicable)
 
*TRANSLITERATION
(if applicable)
 
*CLAIMED PRIOR REGISTRATION
(if applicable)
 
*CONSENT (NAME/LIKENESS)
(if applicable)
*CONCURRENT USE CLAIM
(if applicable)
 
ATTORNEY INFORMATION
NAME Bruce Hare
ATTORNEY BAR MEMBERSHIP NUMBER XXX
YEAR OF ADMISSION XXXX
U.S. STATE/ COMMONWEALTH/ TERRITORY XX
FIRM NAME Genius Patent APC
STREET 2305 Historic Decatur Road, Suite 100
CITY San Diego
STATE California
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
ZIP/POSTAL CODE 92106
PHONE 619-880-9464
FAX 6193319524
EMAIL ADDRESS bruce@geniuspatent.com
CORRESPONDENCE INFORMATION
NAME Bruce Hare
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE bruce@geniuspatent.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) admin@geniuspatent.com
FEE INFORMATION
APPLICATION FILING OPTION TEAS Plus
NUMBER OF CLASSES 1
APPLICATION FOR REGISTRATION PER CLASS 250
*TOTAL FEES DUE 250
*TOTAL FEES PAID 250
SIGNATURE INFORMATION
* SIGNATURE /Paul Edalat/
* SIGNATORY'S NAME Paul Edalat
* SIGNATORY'S POSITION President
SIGNATORY'S PHONE NUMBER 949-234-6161
* DATE SIGNED 08/26/2021
SIGNATURE METHOD Sent to third party for signature



PTO- 1478
Approved for use through 08/31/2021. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number


Trademark/Service Mark Application, Principal Register

TEAS Plus Application

Serial Number: 90904032
Filing Date: 08/26/2021

To the Commissioner for Trademarks:

MARK: Conversall, ellipsis (stylized and/or with design, see mark)
The literal element of the mark consists of Conversall, ellipsis. The color(s) light blue, blue, red is/are claimed as a feature of the mark. The mark consists of The wording Conversall in blue, with an ellipsis in blue, a stylized word balloon in light blue and red, and a stylized brain icon in blue.
The applicant, Vivera Pharmaceuticals Inc., a corporation of Delaware, having an address of
      4533 Macarthur Blvd, #5049
      Newport Beach, California 92660
      United States
      949-234-6161(phone)
      XXXX

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

For specific filing basis information for each item, you must view the display within the Input Table.
International Class 005:  Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Gelatin capsules sold empty for pharmaceuticals; Medicinal preparations for mental health disorders; Medicinal preparations for stuttering; Medicinal preparations for diabetes; Dietary supplements; Drug delivery agents in the form of sublingual tablets that facilitate the delivery of pharmaceutical preparations; Drug delivery agents in the form of sublingual capsules that facilitate the delivery of pharmaceutical preparations; Drug delivery agents in the form of sublingual gel strips that facilitate the delivery of pharmaceutical preparations; Medical preparations for the treatment of mental health disorders; Medical preparations for the treatment of stuttering; Medical preparations for the treatment of diabetes; Nutritional supplements; Pharmaceutical preparations for mental health disorders; Pharmaceutical preparations for stuttering; Pharmaceutical preparations for diabetes; Prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets and pharmaceutical preparations for the treatment of cardiovascular disorders; Sexual stimulant preparations in the form of sublingual tablets containing sildenafil citrate; Sexual stimulant preparations in the form of sublingual capsules containing sildenafil citrate; Sexual stimulant preparations in the form of sublingual gel strips containing sildenafil citrate
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services. (15 U.S.C. Section 1051(b)).




The owner's/holder's proposed attorney information: Bruce Hare. Bruce Hare of Genius Patent APC, is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, is located at
      2305 Historic Decatur Road, Suite 100
      San Diego, California 92106
      United States
      619-880-9464(phone)
      6193319524(fax)
      bruce@geniuspatent.com

Bruce Hare submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any U.S. Commonwealth or territory.

The applicant's current Correspondence Information:
      Bruce Hare
       PRIMARY EMAIL FOR CORRESPONDENCE: bruce@geniuspatent.com
       SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): admin@geniuspatent.com


Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $250 has been submitted with the application, representing payment for 1 class(es).

Declaration

Declaration Signature

Signature: /Paul Edalat/   Date: 08/26/2021
Signatory's Name: Paul Edalat
Signatory's Position: President
Signatory's Phone Number: 949-234-6161
Signature method: Sent to third party for signature
Payment Sale Number: 90904032
Payment Accounting Date: 08/26/2021

Serial Number: 90904032
Internet Transmission Date: Thu Aug 26 14:09:52 ET 2021
TEAS Stamp: USPTO/FTK-XXXX:XXXX:XXXX:XXXX:XXXX:XXXX:
XXXX:XXXX-20210826140952950163-90904032-
78159e798787a9ae761a5eed1c6357aa43119ec0
9dd799bffdfdb76725aa47d4b-CC-09511125-20
210826130328016900

TEAS Plus New Application [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed